Wealthspire Advisors (New York)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$373K Sell
2,674
-6,255
-70% -$876K ﹤0.01% 664
2025
Q4
$1.1M Buy
8,929
+6,937
+348% +$843K 0.01% 411
2025
Q3
$221K Sell
1,992
-689
-26% -$78.3K ﹤0.01% 761
2025
Q2
$297K Buy
2,681
+437
+19% +$46.5K ﹤0.01% 668
2025
Q1
$251K Sell
2,244
-442
-16% -$45.6K ﹤0.01% 684
2024
Q4
$248K Buy
+2,686
New +$242K ﹤0.01% 689
2023
Q1
Sell
-5,368
Closed -$461K 555
2022
Q4
$461K Buy
+5,368
New +$425K 0.01% 381
2022
Q1
Sell
-6,716
Closed -$488K 483
2021
Q4
$488K Sell
6,716
-261
-4% -$18K 0.01% 325
2021
Q3
$487K Buy
+6,977
New +$490K 0.01% 360
2021
Q2
Sell
-9,177
Closed -$593K 492
2021
Q1
$593K Buy
9,177
+2,426
+36% +$156K 0.01% 353
2020
Q4
$393K Sell
6,751
-566
-8% -$34.2K 0.01% 354
2020
Q3
$462K Sell
7,317
-2,707
-27% -$188K 0.03% 191
2020
Q2
$771K Sell
10,024
-7,947
-44% -$609K 0.05% 121
2020
Q1
$1.34M Buy
17,971
+12,644
+237% +$874K 0.06% 162
2019
Q4
$346K Buy
5,327
+99
+2% +$6.45K 0.03% 132
2019
Q3
$331K Buy
+5,228
New +$342K 0.03% 108
2019
Q1
Sell
-850
Closed -$53K 336
2018
Q4
$53K Buy
+850
New +$59.4K 0.01% 178

Other funds holding GILD

Wealthspire Advisors (New York)'s GILD Position: Q1 2026 in Review

Wealthspire Advisors (New York) reduced its Gilead Sciences (GILD) stake by 70% in Q1 2026, selling an estimated $876K and leaving 2,674 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #664.

Wealthspire Advisors (New York) first reported a position in GILD in Q4 2018 and has held it in 17 quarters since. The position peaked at $1.34M in Q1 2020. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Wealthspire Advisors (New York) held 2,674 shares of Gilead Sciences worth $373K as of Q1 2026.
  • Wealthspire Advisors (New York) sold 6,255 Gilead Sciences shares in Q1 2026, an estimated $876K.
  • Gilead Sciences made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q1 2026, its #664 holding.
  • Wealthspire Advisors (New York) first reported a position in Gilead Sciences in Q4 2018 and has held it in 17 quarters since.
  • Wealthspire Advisors (New York)'s Gilead Sciences position peaked at $1.34M in Q1 2020.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q1 2026, filed 1 May 2026.